Top

Gepubliceerd in:

2009 | OriginalPaper | Hoofdstuk

13 Alcoholische leverziekte

Auteur : Prof.dr. P.L.M. Jansen

Uitgeverij: Bohn Stafleu van Loghum

Samenvatting

Door de gunstige effecten van alcohol op hart- en vaatziekten is de belangstelling voor alcohol als veroorzaker van levercirrose en levercarcinoom wat op de achtergrond geraakt. Toch is alcohol de meest voorkomende oorzaak van levercirrose. Tevens speelt alcoholmisbruik een belangrijke rol bij pancreatitis, neuropsychiatrische stoornissen, kanker van de slokdarm, mond-keelholte en borst, en bij verkeersongelukken en geweldsmisdrijven.

vorige hoofdstuk 12 Niet-alcoholische steatohepatitis

volgende hoofdstuk 14 Metabole leverziekten

Bell H, Tallaksen CM, Try K, Haug E. Carbohydratedeficient transferrin and other markers of high alcohol consumption: a study of 502 patients admitted consecutively to a medical department. Alcohol Clin Exp Res 1994;18(5):1103–1108.PubMedCrossRef

Golka K, Wiese A. Carbohydrate-deficient transferrin (CDT) – a biomarker for long-term alcohol consumption. J Toxicol Environ Health B Crit Rev 2004;7(4): 319–337.PubMedCrossRef

Lefkowitch JH. Morphology of alcoholic liver disease. Clin Liver Dis 2005;9(1):37–53.PubMedCrossRef

Bell H, Jahnsen J, Kittang E, Raknerud N, Sandvik L. Long-term prognosis of patients with alcoholic liver cirrhosis: a 15-year follow-up study of 100 Norwegian patients admitted to one unit. Scand J Gastroenterol 2004;39(9):858–863.PubMedCrossRef

Corrao G, Zambon A, Torchio P, Arico S, La VC, di OF. Attributable risk for symptomatic liver cirrhosis in Italy. Collaborative Groups for the Study of Liver Diseases in Italy. J Hepatol 1998;28(4):608–614.PubMedCrossRef

Kamper-Jorgensen M, Gronbaek M, Tolstrup J, Becker U. Alcohol and cirrhosis: dose-response or threshold effect?. J Hepatol 2004;41(1):25–30.PubMedCrossRef

Bellentani S, Saccoccio G, Costa G, et al. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut 1997;41(6): 845–850.PubMedCentralPubMedCrossRef

Reed T, Page WF, Viken RJ, Christian JC. Genetic predisposition to organ-specific endpoints of alcoholism. Alcohol Clin Exp Res 1996;20(9):1528–1533.PubMedCrossRef

Day CP, Bashir R, James OF, et al. Investigation of the role of polymorphisms at the alcohol and aldehyde dehydrogenase loci in genetic predisposition to alcohol- related end-organ damage. Hepatology 1991;14(5): 798–801.PubMedCrossRef

10.

Grove J, Brown AS, Daly AK, Bassendine MF, James OF, Day CP. The RsaI polymorphism of CYP2E1 and susceptibility to alcoholic liver disease in Caucasians: effect on age of presentation and dependence on alcohol dehydrogenase genotype. Pharmacogenetics 1998; 8(4):335–342.PubMedCrossRef

11.

Grove J, Daly AK, Bassendine MF, Gilvarry E, Day CP. Interleukin 10 promoter region polymorphisms and susceptibility to advanced alcoholic liver disease. Gut 2000;46(4):540–545.PubMedCentralPubMedCrossRef

12.

Grove J, Daly AK, Bassendine MF, Day CP. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology 1997;26(1):143–146.PubMedCrossRef

13.

Becker U, Deis A, Sorensen TI, et al. Prediction of risk of liver disease by alcohol intake, sex, and age: a prospective population study. Hepatology 1996;23(5):1025–1029.PubMedCrossRef

14.

Kerr WC, Fillmore KM, Marvy P. Beverage-specific alcohol consumption and cirrhosis mortality in a group of English-speaking beer-drinking countries. Addiction 2000;95(3):339–346.PubMedCrossRef

15.

Corrao G, Ferrari PA, Galatola G. Exploring the role of diet in modifying the effect of known disease determinants: application to risk factors of liver cirrhosis. Am J Epidemiol 1995;142(11):1136–1146.PubMed

16.

Corrao G, Torchio P, Zambon A, D’Amicis A, Lepore AR, di OF. Alcohol consumption and micronutrient intake as risk factors for liver cirrhosis: a case-control study. The Provincial Group for the study of Chronic Liver Disease. Ann Epidemiol 1998;8(3):154–159.PubMedCrossRef

17.

Corrao G, Zambon A, Bagnardi V, Arico S, Loguercio C, D’Amicis A. Nutrient intakes, nutritional patterns and the risk of liver cirrhosis: an explorative case-control study. Eur J Epidemiol 2004;19(9):861–869.PubMedCrossRef

18.

Corrao G, Lepore AR, Torchio P, et al. The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A casecontrol study. Provincial Group for the Study of Chronic Liver Disease. Eur J Epidemiol 1994;10(6):657–664.PubMedCrossRef

19.

Tverdal A, Skurtveit S. Coffee intake and mortality from liver cirrhosis. Ann Epidemiol 2003;13(6):419–423.PubMedCrossRef

20.

Lieber CS, DeCarli L, Rubin E. Sequential production of fatty liver, hepatitis, and cirrhosis in sub-human primates fed ethanol with adequate diets. Proc Natl Acad Sci USA 1975;72(2):437–441.PubMedCentralPubMedCrossRef

21.

Jeong WI, Park O, Gao B. Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis. Gastroenterology 2008;134(1):248–258.PubMedCentralPubMedCrossRef

22.

McCormick PA, Morgan MY, Phillips A, Yin TP, McIntyre N, Burroughs AK. The effects of alcohol use on rebleeding and mortality in patients with alcoholic cirrhosis following variceal haemorrhage. J Hepatol 1992;14(1):99–103.PubMedCrossRef

23.

Teli MR, Day CP, Burt AD, Bennett MK, James OF. Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 1995;346(8981):987–990.PubMedCrossRef

24.

Poynard T, Mathurin P, Lai CL, et al. A comparison of fibrosis progression in chronic liver diseases. J Hepatol 2003;38(3):257–265.PubMedCrossRef

25.

Rambaldi A, Gluud C. Colchicine for alcoholic and non-alcoholic liver fibrosis and cirrhosis. Cochrane Database Syst Rev 2005;2:CD002148.

26.

Rambaldi A, Gluud C. Meta-analysis of propylthiouracil for alcoholic liver disease – a Cochrane Hepato- Biliary Group Review. Liver 2001;21(6):398–404.PubMedCrossRef

27.

Carithers RL Jr, Herlong HF, Diehl AM, et al. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med 1989;110(9):685–690.PubMedCrossRef

28.

Maddrey WC, Boitnott JK, Bedine MS, Weber FL Jr, Mezey E, White RI Jr. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978;75(2):193–199.PubMed

29.

Mathurin P, Mendenhall CL, Carithers RL Jr, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. J Hepatol 2002;36(4):480–487.PubMedCrossRef

30.

Ramond MJ, Poynard T, Rueff B, et al. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med 1992;326(8):507–512.PubMedCrossRef

31.

Louvet A, Naveau S, Abdelnour M, et al. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology 2007;45(6):1348–1354.PubMedCrossRef

32.

Naveau S, Chollet-Martin S, Dharancy S, et al. A double- blind randomized controlled trial of infliximab associated with prednisolone in acute alcoholic hepatitis. Hepatology 2004;39(5):1390–1397.PubMedCrossRef

33.

Akriviadis E, Botla R, Briggs W, Han S, Reynolds T, Shakil O. Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. Gastroenterology 2000;119(6): 1637–1648.PubMedCrossRef

34.

Hutchinson SJ, Bird SM, Goldberg DJ. Influence of alcohol on the progression of hepatitis C virus infection: a meta-analysis. Clin Gastroenterol Hepatol 2005; 3(11):1150–1159.PubMedCrossRef

35.

Corrao G, Torchio P, Zambon A, Ferrari P, Arico S, di OF. Exploring the combined action of lifetime alcohol intake and chronic hepatotropic virus infections on the risk of symptomatic liver cirrhosis. Collaborative Groups for the Study of Liver Diseases in Italy. Eur J Epidemiol 1998;14(5):447–456.PubMedCrossRef

36.

Pessione F, Degos F, Marcellin P, et al. Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology 1998;27(6):1717–1722.PubMedCrossRef

37.

Anand BS, Currie S, Dieperink E, et al. Alcohol use and treatment of hepatitis C virus: results of a national multicenter study. Gastroenterology 2006;130(6):1607–1616.PubMedCrossRef

Titel: 13 Alcoholische leverziekte
Auteur: Prof.dr. P.L.M. Jansen
Uitgeverij: Bohn Stafleu van Loghum
Boek: Leverziekten
Print ISBN: 978-90-313-7436-6

Elektronisch ISBN: 978-90-313-7437-3

Copyright: 2009
DOI: https://doi.org/10.1007/978-90-313-7437-3_13

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Samenvatting

Log in om toegang te krijgen